[{"_id":"5641e94efd1ef1594b89ca88","決算期":"2015年3月期","証券コード":"4555","会社名":"沢井製薬(株)【4555】","会計方式":"日本方式","決算発表日":"2015年5月14日","決算月数":"12か月","売上高":"105,454百万円","営業利益":"20,688百万円","経常利益":"20,619百万円","当期利益":"14,053百万円","EPS（一株当たり利益）":"382.26円","調整一株当たり利益":"381.85円","BPS（一株当たり純資産）":"3,053.29円","総資産":"166,179百万円","自己資本":"112,311百万円","資本金":"27,124百万円","有利子負債":"11,176百万円","自己資本比率":"67.6%","ROA（総資産利益率）":"8.91%","ROE（自己資本利益率）":"13.16%","総資産経常利益率":"13.07%","日付":"2015-11-10T12:55:42.789Z"},{"_id":"5641e94efd1ef1594b89ca89","決算期":"2014年3月期","証券コード":"4555","会社名":"沢井製薬(株)【4555】","会計方式":"日本方式","決算発表日":"2014年5月14日","決算月数":"12か月","売上高":"89,823百万円","営業利益":"19,090百万円","経常利益":"19,091百万円","当期利益":"12,192百万円","EPS（一株当たり利益）":"365.18円","調整一株当たり利益":"330.41円","BPS（一株当たり純資産）":"2,755.29円","総資産":"149,348百万円","自己資本":"101,234百万円","資本金":"27,106百万円","有利子負債":"8,629百万円","自己資本比率":"67.8%","ROA（総資産利益率）":"8.80%","ROE（自己資本利益率）":"14.99%","総資産経常利益率":"13.77%","日付":"2015-11-10T12:55:42.789Z"},{"_id":"5641e94efd1ef1594b89ca8a","決算期":"2013年3月期","証券コード":"4555","会社名":"沢井製薬(株)【4555】","会計方式":"日本方式","決算発表日":"2013年5月14日","決算月数":"12か月","売上高":"80,502百万円","営業利益":"17,384百万円","経常利益":"17,601百万円","当期利益":"12,022百万円","EPS（一株当たり利益）":"773.42円","調整一株当たり利益":"636.35円","BPS（一株当たり純資産）":"4,054.29円","総資産":"127,842百万円","自己資本":"61,425百万円","資本金":"11,959百万円","有利子負債":"36,316百万円","自己資本比率":"48.0%","ROA（総資産利益率）":"9.57%","ROE（自己資本利益率）":"20.05%","総資産経常利益率":"14.01%","日付":"2015-11-10T12:55:42.789Z"}]